FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
19 letters match. Newest first.
-
DrugsLakpura LLC
FDA and Federal Trade Commission warned Lakpura LLC over ayurvedic products and teas with unapproved COVID-19 claims.
High risk -
DrugsBespoke Apothecary LLC
Bespoke Apothecary sold COVID kit and herbal tea with unapproved COVID-19 treatment claims, FDA and FTC say.
Low -
DrugsFluxxLab LLC
FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.
High risk -
DrugsKlarity Kratom
Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.
High risk -
DrugsMONQ, LLC
MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.
High risk -
DrugsSensory Cloud, Inc
FDA and FTC warn Sensory Cloud that its FEND nasal mister is an unapproved, misbranded drug sold with COVID-19 prevention and treatment claims.
High risk -
DrugsFunctional Remedies, LLC D/B/A Synchronicity Hemp Oil
FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsGreenway Herbal Products LLC
FDA and FTC warned GreenWay Herbal Products that CBD website claims to prevent and treat COVID-19 make its products unapproved, misbranded drugs.
High risk -
DrugsCureganics
Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.
High risk -
DrugsNature's Highway
FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.
High risk -
FoodPharmaganics LLC
FDA and FTC warn Pharmaganics over diabetes supplement claims that make unapproved, misbranded drugs.
High risk -
FoodPhytag Labs
FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.
Medium -
FoodNuturna International LLC
Nuturna International marketed 'Diabetic Support Formula' with diabetes-treatment claims, making it an unapproved drug and misbranded.
High risk -
FoodLysulin, Inc.
Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.
High risk -
FoodHolistic Healer & Wellness Center, Inc.
FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.
High risk -
FoodBeauty & Spa Concepts, DBA Beenefits
FDA and FTC warned Beauty & Spa Concepts, DBA Beenefits, over unapproved, misbranded Brazilian Propolis Extract sold with COVID-19 prevention and treatment claims.
High risk -
FoodFertility Nutraceuticals LLC
FDA and FTC told Fertility Nutraceuticals its three fertility supplements are unapproved drugs because of disease-treatment claims online and in shipping inserts.
High risk -
DrugsAllure Imports
Allure Imports sold unapproved Silver Soul and Vitality C60 products claimed to treat COVID-19.
High risk -
DrugsAbout Mineral
FDA and FTC warn About Mineral that its Puriton skin products are unapproved drugs with misleading COVID-19 claims.
High risk